Jubilant Pharmova Limited
NSE:JUBLPHARMA.NS
1,198.7 (INR) • At close September 18, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Jubilant Pharmova Limited |
Symbool | JUBLPHARMA.NS |
Munteenheid | INR |
Prijs | 1,198.7 |
Beurswaarde | 190,930,134,700 |
Dividendpercentage | 0.7% |
52-weken bereik | 318.75 - 1,247.15 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Arvind Chokhany |
Website | https://www.jubilantpharmova.com |
An error occurred while fetching data.
Over Jubilant Pharmova Limited
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)